Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

<p>Molecular landscape of HGSOC. <sup>1</sup>Mutation in non-<i>BRCA1</i>/<i>2</i> HRR genes: 3 <i>BRIP1</i>, 2 <i>CHEK2</i>, 1 <i>RAD51C</i>, 1 <i>PALB2</i>, 1 concurrent <i>BAP1</i> and <i>N...

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Robert L. Hollis (15034814) (author)
Diğer Yazarlar:	Alison M. Meynert (14956260) (author), Caroline O. Michie (15043392) (author), Tzyvia Rye (4733277) (author), Michael Churchman (15034811) (author), Amelia Hallas-Potts (15043395) (author), Ian Croy (15034823) (author), W. Glenn McCluggage (8775452) (author), Alistair R.W. Williams (15043398) (author), Clare Bartos (15034820) (author), Yasushi Iida (4097272) (author), Aikou Okamoto (14957624) (author), Brian Dougherty (108958) (author), J. Carl Barrett (11900099) (author), Ruth March (73809) (author), Athena Matakidou (15034847) (author), Patricia Roxburgh (14961464) (author), Colin A. Semple (15034853) (author), D. Paul Harkin (14873531) (author), Richard Kennedy (248483) (author), C. Simon Herrington (15034817) (author), Charlie Gourley (15034850) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Biology Tumor Biology Therapeutic Research and Development Clinical Research and Trials Gynecological Cancers Ovarian cancer Oncogenes & Tumor Suppressors BRCA family Precision Medicine Translational Research Tumor Microenvironment Immune cells and the microenvironment
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Yazar:: Robert L. Hollis (15034814)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Yazar:: Robert L. Hollis (15034814)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Yazar:: Robert L. Hollis (15034814)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Yazar:: Robert L. Hollis (15034814)
Baskı/Yayın Bilgisi: (2025)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Yazar:: Robert L. Hollis (15034814)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Yazar:: Sanna Pikkusaari (15055802)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Yazar:: Sanna Pikkusaari (15055802)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
Yazar:: Kankan Cao (16437263)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
Yazar:: Arun Kanakkanthara (14937731)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
Yazar:: Arun Kanakkanthara (14937731)
Baskı/Yayın Bilgisi: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
Yazar:: Laura Privitera (16015972)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
Yazar:: Alexander N. Shoushtari (15023909)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer
Yazar:: Anita L. Ray (15313398)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer
Yazar:: Anita L. Ray (15313398)
Baskı/Yayın Bilgisi: (2025)

Tables 2 from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
Yazar:: Simon P. Beyaert (17141915)
Baskı/Yayın Bilgisi: (2025)

Tables 3 from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
Yazar:: Simon P. Beyaert (17141915)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figures SF1-SF9 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
Yazar:: Robin M. Hallett (15037427)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables ST1-ST6 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
Yazar:: Robin M. Hallett (15037427)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 1 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Yazar:: Patrizia Mondello (15045002)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 2 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Yazar:: Patrizia Mondello (15045002)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 3 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Yazar:: Patrizia Mondello (15045002)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 4 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Yazar:: Patrizia Mondello (15045002)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_u83fg12r3do2gh1tgfbinsq77b